Noyori, which contains both a diphosphine and a diamine
(typically DPEN) which cooperatively interact in an ex-
tremely active and enantioselective reduction catalyst.5 This
system works successfully for simple aryl/alkyl ketones,
heterocyclic ketones, and enones. Many variants of this
successful Ru(II)/diphosphine/diamine combination have
been reported.6
prepared by the reaction between S-BINOL and the ap-
propriate bis(dimethylamino)phosphine precursors.
Each ligand was converted to the [L2RuCl2(DPEN)]
complex by reaction with [RuCl2(benzene)]2 followed by
(S,S)-DPEN. The complexes were yellow-brown solids and,
in their solid forms, stable to air and moisture. The structures
of the complexes were confirmed by spectroscopic methods
and by high-resolution mass spectrometry. An X-ray crystal
structure of one of the complexes, that derived from S-8,
was also obtained (Figure 1).
A second significant development in asymmetric hydro-
genation has been the introduction of monodonor chiral
ligands, usually based on the BINOL backbone.8 An example
is Feringa’s MONOPHOS 2.8-10 Rhodium complexes of 2,
typically containing two ligands per metal atom, are capable
of the asymmetric reduction of CdC bonds in outstanding
enantioselectivities. Best results are obtained with substrates
containing coordinating functions, such as R-acylamino-
acrylates and unsaturated carboxylic acids.1,4 Given the
excellent results obtained with BINOL-derived monodonor
phosphorus ligands, we wished to establish whether such
ligands could also replace diphosphines such as BINAP in
1. If so, then this would have a significant advantage in terms
of practicality, since the monodonor ligands are less expen-
sive and more readily available than most chiral bidentate
ligands. Toward this end, we prepared a series of BINOL-
derived ligands. In addition to phosphoramidite 2,8 we
prepared the known phosphite 3 and phosphonite 4.9,10 We
also prepared a series of ligands 5-9 containing a substituted
aromatic ring attached to the P atom. Ligands 5 and 7 have
been reported previously;9a,d,e,11 however, ligands 6, 8, and
9 are, to the best of our knowledge, new. The ligands were
Figure 1. X-ray crystallographic structure of the (S,S,SS)-Ru(II)‚
DPEN complex derived from 8.
An investigation into the applications of the new com-
plexes to the asymmetric hydrogenation of simple ketones
was undertaken (Scheme 1). In the first stage of the study,
Scheme 1
the (S,S,SS) complex derived from ligand 8 (‘BrXuPHOS’)12
was selected for a short statistical experimental design study
(MODDE 6).13,14 A total of 17 experiments were carried out
with variation of the substrate concentration, mol % of base,
and the temperature. The substrate was acetophenone, S/C
(7) (a) Jiang, Q.; Jiang, Y.; Xiao, D.; Cao, P.; Zhang, X. Angew. Chem.,
Int. Ed. 1998, 37, 1100.
(8) (a) Pena, D.; Minaard, A. J.; de Vries, A. H. M.; Feringa, B. L. Org.
Lett. 2003, 5, 475. (b) Pena, D.; Minnaard, A. J.; de Vries, J. G.; Feringa,
B. L. J. Am. Chem. Soc. 2002, 124, 14552. (c) Pena, D.; Minnaard, A. J.;
Boogers, J. A. F.; de Vries, A. H. M.; de Vries, J. G.; Feringa, B. L. Org.
Biomol. Chem. 2003, 1087.
(9) (a) Claver, C.; Fernandez, E.; Gillon, A.; Heslop, K.; Hyett, D. J.;
Martorelli, A.; Orpen, A. G.; Pringle, P. G. Chem. Commun. 2000, 961.
(b) Reetz, M. T.; Goossen, L. J.; Meiswinkel, A.; Paetzold, J.; Feldthusen
Jensen, J. Org. Lett. 2003, 5, 3099. (c) Reetz, M. T.; Mehler, G. Tetrahedron
Lett. 2003, 44, 4593. (d) Reetz, M. T.; Sell, T. Tetrahedron Lett. 2000, 41,
6333.
(10) (a) Jia, X.; Li, X.; Shi, Q.; Yao, X.; Chan, A. S. C. J. Org. Chem.
2003, 68, 539-41. (b) Hannen, P.; Militzer, H.-C.; Vogl, E. M.; Rampf, F.
A. Chem. Commun. 2003, 2210. (c) Zhu, S.-F.; Fu, Y.; Xie, J.-H.; Liu, B.;
Xing, L.; Zhou, Q.-L. Tetrahedron Lett. 2003, 14, 3219. (d) Gergely, I.;
Hegedus, C.; Gulyas, H.; Szollosy, A.; Monsees, A.; Riermeier, T.; Bakos,
J. Tetrahedron: Asymmetry 2003, 14, 1087. (e) Huang, H.; Zheng, Z.; Luo,
H.; Bai, C.; Hu, X.; Chen, H. Org. Lett. 2003, 5, 4137. (f) Reetz, M. T.;
Mehler, G.; Meiswinkel, A.; Sell, T. Tetrahedron Lett. 2002, 43, 7941.
(11) (a) Martorell, A.; Naasz, R.; Feringa, B. L.; Pringle, P. G.
Tetrahedron: Asymmetry 2001, 12, 2497. (b) Tillack, A.; Selke, R.; Fischer,
C.; Bilda, D.; Kortus, K. J. Organomet. Chem. 1996, 518, 79.
(12) The suggested trivial name for this ligand acknowledges the first
researcher in the group to prepare and use it.
(13) The (S,S,SS) complex contains the matched combination of con-
figurations. The corresponding complex of (S,S,RR) configuration gave a
lower, reversed configuration of acetophenone reduction product (ca. 33%
ee S).
(14) The MODDE optimised conditions for 8 may not correspond to
those for other ligands.
(15) Fletcher, D. A.; McMeeking, R. F.; Parkin, D. J. Chem. Inf. Comput.
Sci. 1996, 36, 746.
4106
Org. Lett., Vol. 6, No. 22, 2004